Now showing items 1-6 of 6
Myo-inositol oxygenese activity in second trimester of pregnancy: altered myoinositol catabolism in gestational diabetes mellitus
(Taylor & Francis Ltd, 2020)
Objective: We aimed to determine myo-inositol oxygenase (MIOX) activity in gestational diabetes mellitus (GDM). Material and Methods: The insulin, HbA1c, and MIOX levels of 80 pregnant women were analysed after 75 g OGTT. ...
Maternal serum advanced glycation end products level as an early marker for predicting preterm labor/PPROM: a prospective preliminary study
Objective: To evaluate the value of maternal serum advanced glycation end products (AGEs) level at 11–13 weeks’ gestation for the prediction of preterm labor and or preterm premature rupture of membranes (PPROM). Materials ...
Importance of hba1c and fructosamine as a marker of glycemic control and evaluation of some biochemical parameters during pregnancy
Amaç: Diyabetin kontrol ve monitorizasyonu fetal malformasyon, makrozomi ve diğer komplikasyonlar nedeniyle gebelikte özellikle önemlidir. Çalışmamız, monitorizasyonda en sık kullanılan iki parametre olan hemoglobin A1c ...
Pro-Gastrin releasing peptide: a new serum marker for endometrioid adenocarcinoma
Background: Gastrin-releasing peptide (GRP) is thought to play a role in the metastatic process of various malignancies. The more stable precursor of GRP, pro-GRP (ProGRP), has been shown to be secreted by neuroendocrine ...
Ischemia-modified albumin and cardiovascular risk markers in polycystic ovary syndrome with or without insulin resistance
(Elsevier Science Inc, 2011)
The aim of this study was to evaluate ischemia-modified albumin levels (IMA) in polycystic ovary syndrome (PCOS) cases with and without insulin resistance and the correlation of IMA with carotid intima media thickness, ...
Association of anti-Mullerian hormone and small-dense low-density lipoprotein cholesterol with hepatosteatosis in young lean women with and without polycystic ovary syndrome
(Elsevier Science Bv, 2014)
Objective: To study the association of anti-Mullerian hormone (AMH) and small-dense low-density lipoprotein cholesterol (sd-LDL) with hepatosteatosis among young, lean, polycystic ovary patients. Study design: A prospective, ...